Novel bispecific design improves CAR T–cell immunotherapy for childhood leukemia
St. Jude Children's Research HospitalFindings from St. Jude Children’s Research Hospital showed a novel dual targeting approach, where a single molecule can recognize two potential cancer-related proteins, is more effective than the single targeting approach, preventing immune escape.